Clinical trial
Effects of Armodafinil on Cognition for Patients With Schizophrenia or…
NCT00373672 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00373672 |
|---|---|
| Title | Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder |
| Official title | Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression Cephalon Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | armodafinil (Nuvigil), placebo |
| Enrollment | 58 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Sep 8, 2006 |
| Last update posted | Aug 5, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: